N-NITROSOMORPHOLINE |
59-89-2 |
4-Nitrosomorpholine |
Nitrosomorpholine |
Morpholine, 4-nitroso- |
NMOR |
N-Nitrosomorpholin |
Morpholine, N-nitroso- |
N-Nitrosomorfolin |
NCI-C02164 |
4-Nitroso-morpholine |
3L25FO7FN7 |
DTXSID4021056 |
CHEBI:76326 |
NSC-139 |
DTXCID001056 |
NSC 139 |
N-Nitrosomorfolin [Czech] |
CAS-59-89-2 |
N-Nitrosomorpholin [German] |
67587-56-8 |
CCRIS 473 |
Molsidomine impurity B |
HSDB 4308 |
BRN 0112139 |
UNII-3L25FO7FN7 |
N-nitroso morpholine |
N-Nitrosomorpholine solution |
WLN: T6N DOTJ ANO |
N-Nitrosomorpholine (NMOR) |
CHEMBL165908 |
NSC139 |
SCHEMBL1578515 |
N-NITROSOMORPHOLINE [MI] |
N-NITROSOMORPHOLINE [HSDB] |
N-NITROSOMORPHOLINE [IARC] |
Tox21_202132 |
Tox21_302867 |
MFCD00039710 |
STL301087 |
AKOS015903272 |
NCGC00249174-01 |
NCGC00256343-01 |
NCGC00259681-01 |
BS-17191 |
SY052130 |
4-Nitrosomorpholine 0.1 mg/ml in Methanol |
4-Nitrosomorpholine 1.0 mg/ml in Methanol |
DB-053489 |
HY-131123 |
CS-0128913 |
N0466 |
NS00010254 |
C19283 |
N-Nitrosomorpholine 100 microg/mL in Methanol |
T72681 |
EN300-7323775 |
Q22138414 |
Z1255360497 |
Molsidomine impurity B, European Pharmacopoeia (EP) Reference Standard |